⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4738398 | 0.92 | SIGMAR1 (0.39) | — | |
| SCHEMBL4396289 | 0.90 | SIGMAR1 (0.33) | — | |
| SCHEMBL9816 | 0.82 | — | — | |
| SCHEMBL4389342 | 0.82 | SIGMAR1 (0.41) | — | |
| SCHEMBL2462839 | 0.82 | ALDH1A1 (0.32) | — | |
| SCHEMBL20367468 | 0.82 | CHRM2 (0.39) | — | |
| SCHEMBL10783088 | 0.80 | SIGMAR1 (0.45) | — | |
| SCHEMBL7795606 | 0.79 | ALDH1A1 (0.42) | — | |
| SCHEMBL3807307 | 0.79 | ALDH1A1 (0.42) | — | |
| SCHEMBL27075802 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025031991-A1 | STEALTH-STABILIZED SULFUR-CONTAINING LIPO/POLYAMINO ACIDS | POLYPEPTIDE THERAPEUTIC SOLUTIONS, S.L. (ES) | 2025-02-13 | — | — | WO | disclosed |
| WO-2015057803-A1 | METHOD OF GENERATING LINKAGE-SPECIFIC DI-AND POLYPROTEIN PROBES | ZHUANG ZHIHAO (US) | 2015-04-23 | — | — | WO | disclosed |
| US-8252784-B2 | Photoactivable nitrogen bases | BASF SE (DE) | 2012-08-28 | — | — | US | disclosed |
| US-7538104-B2 | Photoactivable nitrogen bases | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-05-26 | — | — | US | disclosed |
| US-20090076200-A1 | Letter with continuation application | BAUDIN GISELE | 2009-03-19 | — | — | US | disclosed |
| EP-1436297-B1 | PHOTOACTIVABLE NITROGEN BASES | CIBA SC HOLDING AG (CH) | 2007-04-25 | — | — | EP | disclosed |
| US-20040242867-A1 | Photoactivable nitrogen bases | CIBA CORPORATION | 2004-12-02 | — | — | US | disclosed |
| EP-1436297-A1 | PHOTOACTIVABLE NITROGEN BASES | Ciba Specialty Chemicals Holding Inc. (CH) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003033500-A1 | PHOTOACTIVABLE NITROGEN BASES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-04-24 | — | — | WO | disclosed |
| US-6159964-A | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2000-12-12 | — | — | US | disclosed |
| EP-0906103-A4 | — | — | 1999-04-07 | — | — | EP | disclosed |
| CN-1209063-A | Vitronection receptor antagonists | SMITHKLINE BEECHAM CORP (US) | 1999-02-24 | — | — | CN | disclosed |
| EP-0888356-A1 | CONDENSED 2,3-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS AMPA-RECEPTOR INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997028163-A1 | CONDENSED 2,3-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS AMPA-RECEPTOR INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-08-07 | — | — | WO | disclosed |
| WO-1997024124-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-07-10 | — | — | WO | disclosed |
| EP-0450995-B1 | New propanamines, their pharmacological properties and their therapeutical applications, notably as anti-diarrhoea agents | JOUVEINAL SA (FR) | 1994-06-08 | — | — | EP | disclosed |
| US-5236947-A | Side effect reduction | JOUVEINAL S.A. (FR) | 1993-08-17 | — | — | US | disclosed |
| US-5143938-A | PROPANAMINES, THEIR PHARMACOLOGICAL PROPERTIES AND THEIR APPLICATION FOR THERAPEUTIC IN PARTICULAR ANTIDIARRHEAL, PURPOSES | JOUVEINAL S.A. (FR) | 1992-09-01 | — | — | US | disclosed |
| EP-0450995-A1 | New propanamines, their pharmacological properties and their therapeutical applications, notably as anti-diarrhoea agents | JOUVEINAL S.A. (FR) | 1991-10-09 | — | — | EP | disclosed |
| US-4255182-A | PRE- AND POSTEMERGENCE HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1981-03-10 | — | — | US | disclosed |